Related Experiment Video
Updated: Feb 2, 2026
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Allelic imbalance and haploinsufficiency in MYBPC3-linked hypertrophic cardiomyopathy
Amelia A Glazier1, Andrea Thompson2, Sharlene M Day3,4
1Department of Molecular and Integrative Physiology, University of Michigan, 7220 MSRB III, 1150 W Medical Center Drive, SPC 0644, Ann Arbor, MI, 48109-5853, USA.
Insights
Familial hypertrophic cardiomyopathy (HCM) is often caused by MYBPC3 mutations. This review explores how allelic imbalance and haploinsufficiency of MYBPC3 contribute to HCM, offering insights for future therapies.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Mutations in cardiac myosin binding protein C (MYBPC3) are the leading cause of familial hypertrophic cardiomyopathy (HCM), accounting for about 50% of identified cases.
- Unlike other sarcomere genes in HCM, MYBPC3 mutations are predominantly truncating.
- Studies show reduced wild-type MYBPC3 in HCM patient hearts, suggesting haploinsufficiency, and decreased mutant mRNA with absent truncated protein, indicating allelic imbalance.
Purpose of the Study:
- To introduce the concepts of allelic imbalance and haploinsufficiency and their general role in human disease.
- To specifically examine the roles of allelic imbalance and haploinsufficiency in MYBPC3-linked HCM.
- To discuss the implications of these findings for future HCM research and therapeutic development.
Main Methods:
- Review of existing scientific literature on MYBPC3 mutations, hypertrophic cardiomyopathy, allelic imbalance, and haploinsufficiency.
- Analysis of findings from studies using myocardial tissue from HCM patients and control hearts.
- Synthesis of information to connect molecular mechanisms to clinical manifestations and research directions.
Main Results:
- MYBPC3 mutations are the most common cause of familial HCM.
- Truncating mutations are characteristic of MYBPC3-associated HCM.
- Evidence suggests both haploinsufficiency of full-length MYBPC3 and allelic imbalance contribute to the disease pathology.
Conclusions:
- Allelic imbalance and haploinsufficiency are critical mechanisms in MYBPC3-linked HCM.
- A deeper understanding of these phenomena can improve genotype-phenotype correlations in HCM.
- This knowledge may pave the way for novel, targeted therapeutic strategies for hypertrophic cardiomyopathy.
Abstract:
Mutations in cardiac myosin binding protein C (MYBPC3) represent the most frequent cause of familial hypertrophic cardiomyopathy (HCM), making up approximately 50% of identified HCM mutations. MYBPC3 is distinct among other sarcomere genes associated with HCM in that truncating mutations make up the vast majority, whereas nontruncating mutations predominant in other sarcomere genes. Several studies using myocardial tissue from HCM patients have found reduced abundance of wild-type MYBPC3 compared to control hearts, suggesting haploinsufficiency of full-length MYBPC3. Further, decreased mutant versus wild-type mRNA and lack of truncated mutant MYBPC3 protein has been demonstrated, highlighting the presence of allelic imbalance. In this review, we will begin by introducing allelic imbalance and haploinsufficiency, highlighting the broad role each plays within the spectrum of human disease. We will subsequently focus on the roles allelic imbalance and haploinsufficiency play within MYBPC3-linked HCM. Finally, we will explore the implications of these findings on future directions of HCM research. An improved understanding of allelic imbalance and haploinsufficiency may help us better understand genotype-phenotype relationships in HCM and develop novel targeted therapies, providing exciting future research opportunities.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
01:49Multiple Allele Traits
01:30Cardiomyopathy II: Dilated Cardiomyopathy
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
01:10Homeostatic Imbalance
However, sometimes these feedback loops fail,...
02:41Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...